Evidence map›Paper›PMID 28440342›Full record

ArticleThe pharmacogenomics journal2018

Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest.

D J Pappas, A Lizee, V Paunic, K R Beutner, A Motyer, D Vukcevic, S Leslie, J Biesiada, J Meller, K D Taylor and 6 more

Open access · greenAbstract read
In one paragraph

Article in The pharmacogenomics journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. A specific amino acid motif ofProceedings of the National Academy of Sciences of the United States of America · 2019
    Trial
  3. Shared Epitope-PositiveNeurology(R) neuroimmunology & neuroinflammation · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Imputation-Based HLA Typing with GWAS SNPs.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genetic Determinants inJournal of personalized medicine · 2021
    Review
  18. Review
  19. An immunogenetic view of COVID-19.Genetics and molecular biology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 3 countries.

D J PappasCenter for Genetics, Children's Hospital Research Institute, Oakland, CA, USA.
A LizeeDepartment of Neurology, University of California, San Francisco, CA, USA.
V PaunicBioinformatics Research Department, National Marrow Donor Program, Minneapolis, MN, USA.
K R BeutnerDepartment of Neurology, University of California, San Francisco, CA, USA.
A MotyerCentre for Systems Genomics, Schools of Mathematics and Statistics, and BioSciences, The University of Melbourne, Melbourne, VIC, Australia.
D VukcevicCentre for Systems Genomics, Schools of Mathematics and Statistics, and BioSciences, The University of Melbourne, Melbourne, VIC, Australia.
S LeslieCentre for Systems Genomics, Schools of Mathematics and Statistics, and BioSciences, The University of Melbourne, Melbourne, VIC, Australia.
J BiesiadaDepartment of Biomedical Informatics, Cincinnati Children's Hospital Medical Center & Department of Environmental Health, University of Cincinnati, Cincinnati, OH, USA.
J MellerDepartment of Biomedical Informatics, Cincinnati Children's Hospital Medical Center & Department of Environmental Health, University of Cincinnati, Cincinnati, OH, USA.
K D TaylorLos Angeles Biomedical Research Institute, Torrance, CA, USA.
X ZhengDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
L P ZhaoFred Hutchinson Cancer Research Center, Seattle, WA, USA.
P-A GourraudDepartment of Neurology, University of California, San Francisco, CA, USA.
J A HollenbachDepartment of Neurology, University of California, San Francisco, CA, USA.
S J MackCenter for Genetics, Children's Hospital Research Institute, Oakland, CA, USA.
M MaiersBioinformatics Research Department, National Marrow Donor Program, Minneapolis, MN, USA.
University of California, San Francisco · USMurdoch Children's Research Institute · AUNational Marrow Donor Program · USCincinnati Children's Hospital Medical Center · USFondation de l'Avenir · FRFred Hutch Cancer Center · USThe Lundquist Institute · USUniversity of Cincinnati · USUniversity of Melbourne · AUUniversity of Washington · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
A Haplotype Map for Multiple SclerosisR01NS049477 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAUSER, STEPHEN L · 2005 to 2014
$15.3M
The Role of HLA and KIR in Rheumatoid Arthritis and Crohn's DiseaseU01AI067068 · NIAID · STANFORD UNIVERSITY · PI ERLICH, HENRY A, TRACHTENBERG, ELIZABETH A · 2005 to 2014
$10.9M
Systemic Lupus Erythematosus and Ulcerative Colitis StudyU19AI067152 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAMMARSTROM, LENNART · 2005 to 2009
$10.1M
Statistical Methods for X-Chromosome Genetic DataP01GM099568 · NIGMS · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2012 to 2016
$7.3M
Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic DataR01AI128775 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JILL Allison HOLLENBACH, STEVEN JOHN MACK · 2017 to 2026
$4.5M
Immunogenetic Studies in Multiple SclerosisR01NS046297 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OKSENBERG, JORGE R. · 2003 to 2013
$3.5M
The contribution of common and rare variants to autoimmunity in African AmericansR01NS076492 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OKSENBERG, JORGE R. · 2011 to 2014
$1.3M
Integrated Exchange & Storage of Current and Future-Generation Immunogenomic DataR01GM109030 · NIGMS · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI HOLLENBACH, JILL ALLISON, MACK, STEVEN JOHN · 2014 to 2016
$919k
NCATS NIH HHS UL1 TR001881NIAID NIH HHS R01 AI128775NIAID NIH HHS U01 AI067068NIAID NIH HHS U19 AI067152NIDDK NIH HHS P30 DK063491NIGMS NIH HHS P01 GM099568NIGMS NIH HHS R01 GM109030NINDS NIH HHS R01 NS046297NINDS NIH HHS R01 NS049477NINDS NIH HHS R01 NS076492
6 · The paper itself

Abstract

Four single nucleotide polymorphism (SNP)-based human leukocyte antigen (HLA) imputation methods (e-HLA, HIBAG, HLA*IMP:02 and MAGPrediction) were trained using 1000 Genomes SNP and HLA genotypes and assessed for their ability to accurately impute molecular HLA-A, -B, -C and -DRB1 genotypes in the Human Genome Diversity Project cell panel. Imputation concordance was high (>89%) across all methods for both HLA-A and HLA-C, but HLA-B and HLA-DRB1 proved generally difficult to impute. Overall, <27.8% of subjects were correctly imputed for all HLA loci by any method. Concordance across all loci was not enhanced via the application of confidence thresholds; reliance on confidence scores across methods only led to noticeable improvement (+3.2%) for HLA-DRB1. As the HLA complex is highly relevant to the study of human health and disease, a standardized assessment of SNP-based HLA imputation methods is crucial for advancing genomic research. Considerable room remains for the improvement of HLA-B and especially HLA-DRB1 imputation methods, and no imputation method is as accurate as molecular genotyping. The application of large, ancestrally diverse HLA and SNP reference data sets and multiple imputation methods has the potential to make SNP-based HLA imputation methods a tractable option for determining HLA genotypes.

Indexed as

HaplotypesAllelesGenetic VariationGenome, HumanGenome-Wide Association StudyGenotypeHLA-A AntigensHLA AntigensHLA-B AntigensHLA-C AntigensHLA-DRB1 ChainsHumansPolymorphism, Single NucleotideWhite PeopleHLA-A AntigensHLA AntigensHLA-B AntigensHLA-C AntigensHLA-DRB1 Chains

Identifiers

PMID28440342
PMCPMC5656547
OpenAlexW2608242572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.